 |
|
|
 |
|
Early Breast Cancer No More Likely to Return in Young Women
|
 |  |  |  | Related Healthscout Videos |  |
|
Page: << Prev | 1 | 2 Prior studies did find a higher risk of recurrence in younger women with DCIS, she said, but those studies also had some methodology problems, including using varying definitions for DCIS.
One expert applauded the new study.
"They have debunked the commonly held belief that age alone is a risk factor for recurrence after treatment of DCIS," said Dr. Ann Partridge, a medical oncologist and researcher at the Dana-Farber Cancer Institute and Brigham and Women's Hospital, in Boston.
Text Continues Below

Partridge has published about women's anxiety over their prognosis when diagnosed with a DCIS. She found that women are typically highly anxious, even though their risk of recurrence or of developing invasive breast cancer is low.
"I think this is a good study," Partridge said, although it does have limitations. For instance, she said, it is a single-institution study. However, Fox Chase physicians "are doing what they should be doing," Partridge said, explaining that the institution is careful about selecting the right treatment for the right patients, based on the characteristics of their cancer.
More information
There's more on DCIS at breastcancer.org.
Page: << Prev | 1 | 2
|
Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 9/24/2008
|
 |

SOURCES: Aruna Turaka, M.D., fellow, department of radiation oncology, Fox Chase Cancer Center, Philadelphia; Ann Partridge, M.D., medical oncologist and researcher, Dana-Farber Cancer Institute and Brigham & Women's Hospital, Boston; Sept. 24, 2008, presentation, American Society for Therapeutic Radiology and Oncology annual meeting, Boston
|